Bcl-B: an “unknown” protein of the Bcl-2 family

Analysis of circRNA profiles and clinical value in Stevens‐Johnson syndrome and toxic epidermal necrolysis

(2023) Pan Lv et al.   EXPERIMENTAL DERMATOLOGY

Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca2+ traffic and response to neoadjuvant chemotherapy

(2023) Minh Quang Duong et al.   Cell Death & Disease

Targeting MCL-1 protein to treat cancer: opportunities and challenges

(2023) Shady I. Tantawy et al.   Frontiers in Oncology

Last but not least: BFL-1 as an emerging target for anti-cancer therapies

(2022) Gaoyuan Wang et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Expression patterns and biological function of BCL2L10 during mouse preimplantation development

(2022) Yong Liu et al.   GENE EXPRESSION PATTERNS

BCL2 inhibitors and MCL1 inhibitors for hematological malignancies

(2021) Andrew W. Roberts et al.   BLOOD

UBQLN4 is an ATM substrate that stabilizes the anti‐apoptotic proteins BCL2A1 and BCL2L10 in mesothelioma

(2021) Fang Liu et al.   Molecular Oncology

circTADA2A Retards the Progression of Colorectal Cancer via Regulating miR-1229/BCL2L10 Signal Axis

(2021) Li Hu et al.   Cancer Management and Research

Isolation, characterisation, anticancer and anti-oxidant activities of 2-methoxy mucic acid from Rhizophora apiculata: an in vitro and in silico studies

(2021) A. Parthiban et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

BCL-w: apoptotic and non-apoptotic role in health and disease

(2020) Mariusz L. Hartman et al.   Cell Death & Disease

Severe Phenotype in a Patient With Homozygous 15q21.2 Microdeletion Involving BCL2L10, GNB5, and MYO5C Genes, Resembling Infantile Developmental Disorder With Cardiac Arrhythmias (IDDCA)

(2020) Francesca L. Sciacca et al.   Frontiers in Genetics

BCL2L10 Is Overexpressed in Melanoma Downstream of STAT3 and Promotes Cisplatin and ABT-737 Resistance

(2020) María Josefina Quezada et al.   Cancers

Effects of annexin A7 inhibitor-ABO on the expression and distribution of long noncoding RNA-CERNA1 in vascular endothelial cells apoptosis

(2019) Wei Lu et al.   APOPTOSIS

BCL2L10/BECN1 modulates hepatoma cells autophagy by regulating PI3K/AKT signaling pathway

(2019) Jiafa He et al.   Aging-US

Molecular Comprehension of Mcl-1: From Gene Structure to Cancer Therapy

(2019) Viacheslav V. Senichkin et al.   TRENDS IN CELL BIOLOGY

Bcl-XL: A multifunctional anti-apoptotic protein

(2019) Mingxue Li et al.   PHARMACOLOGICAL RESEARCH

Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10

(2018) Adrien Nougarede et al.   CANCER RESEARCH

B cell lymphoma 2 (Bcl-2) residues essential for Bcl-2's apoptosis-inducing interaction with Nur77/Nor-1 orphan steroid receptors

(2018) Karl L. Banta et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Role of BCL2L10 in regulating buffalo ( Bubalus bubalis ) oocyte maturation

(2018) Yu-Lin Huang et al.   THERIOGENOLOGY

Genetic variations using whole-exome sequencing might predict response for neoadjuvant chemoradiotherapy in locally advanced rectal cancer

(2018) In Hee Lee et al.   MEDICAL ONCOLOGY

MicroRNA-18a promotes hepatocellular carcinoma proliferation, migration, and invasion by targeting Bcl2L10

(2018) Xiaodong Wang et al.   OncoTargets and Therapy

BCL2L10 positive cells in bone marrow are an independent prognostic factor of azacitidine outcome in myelodysplastic syndrome and acute myeloid leukemia

(2017) Valérie Vidal et al.   Oncotarget

A balanced translocation disruptingBCL2L10andPNLDC1segregates with affective psychosis

(2016) Christian G. Bouwkamp et al.   AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS

Bcl2l10, a new Tpx2 binding partner, is a master regulator of Aurora kinase A in mouse oocytes

(2016) Su-Yeon Lee et al.   CELL CYCLE

BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice

(2016) Mohamed-Amine Hamouda et al.   JOURNAL OF EXPERIMENTAL MEDICINE

BCL2L10 inhibits growth and metastasis of hepatocellular carcinoma both in vitro and in vivo

(2016) Yun Bai et al.   MOLECULAR CARCINOGENESIS

IRBIT controls apoptosis by interacting with the Bcl-2 homolog, Bcl2l10, and by promoting ER-mitochondria contact

(2016) Benjamin Bonneau et al.   eLife

Lessons from gain- and loss-of-function models of pro-survival Bcl2 family proteins: implications for targeted therapy

(2015) Maja Sochalska et al.   FEBS Journal

BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients

(2015) Thomas Cluzeau et al.   Oncotarget

Antiapoptotic potency of Bcl-2 proteins primarily relies on their stability, not binding selectivity

(2014) R. W. Rooswinkel et al.   BLOOD

Subcellular dynamics of the maternal cell death regulator BCL2L10 in human preimplantation embryos

(2013) Jean-François Guérin et al.   HUMAN REPRODUCTION

Upregulation of miR-18a-5p contributes to epidermal necrolysis in severe drug eruptions

(2013) Asako Ichihara et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

TheBCL2L10Leu21Arg variant and risk of therapy-related myeloid neoplasms andde novomyelodysplastic syndromes

(2013) Emiliano Fabiani et al.   LEUKEMIA & LYMPHOMA

Polyubiquitination and proteasomal turnover controls the anti-apoptotic activity of Bcl-B

(2013) B van de Kooij et al.   ONCOGENE

The anti-apoptotic Bcl-B protein inhibits BECN1-dependent autophagic cell death

(2012) Guillaume Robert et al.   Autophagy

Homology Modeling and Docking Studies of Human Bcl-2L10 Protein

(2012) K. Bhargavi et al.   JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS

Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia

(2012) E Lainey et al.   ONCOGENE

Diva Reduces Cell Death in Response to Oxidative Stress and Cytotoxicity

(2012) Nicole Suyun Liu et al.   PLoS One

Ubiquitination, localization, and stability of an anti-apoptotic BCL2-like protein, BCL2L10/BCLb, are regulated by Ubiquilin1

(2012) L. J. Beverly et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Bcl-2 is a better ABT-737 target than Bcl-xL or Bcl-w and only Noxa overcomes resistance mediated by Mcl-1, Bfl-1, or Bcl-B

(2012) R W Rooswinkel et al.   Cell Death & Disease

The restricted binding repertoire of Bcl-B leaves Bim as the universal BH3-only prosurvival Bcl-2 protein antagonist

(2012) G J P Rautureau et al.   Cell Death & Disease

High-Throughput Screen for the Chemical Inhibitors of Antiapoptotic Bcl-2 Family Proteins by Multiplex Flow Cytometry

(2011) Ramona F. Curpan et al.   ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES

An antiapoptotic BCL-2 family expression index predicts the response of chronic lymphocytic leukemia to ABT-737

(2011) S. Al-harbi et al.   BLOOD

Involvement of BCL2 family members in the regulation of human oocyte and early embryo survival and death: gene expression and beyond

(2011) Imene Boumela et al.   REPRODUCTION

Loss of BCL2L10 protein expression as prognostic predictor for poor clinical outcome in gastric carcinoma

(2010) Jing Da Xu et al.   HISTOPATHOLOGY

BCL2L10 protein regulates apoptosis/proliferation through differential pathways in gastric cancer cells

(2010) Jing Da Xu et al.   JOURNAL OF PATHOLOGY

Role of Bcl2-like 10 (Bcl2l10) in Regulating Mouse Oocyte Maturation1

(2009) Se-Jin Yoon et al.   BIOLOGY OF REPRODUCTION

Oocytes and early embryos selectively express the survival factor BCL2L10

(2009) Yannis Guillemin et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Bcl-B Expression in Human Epithelial and Nonepithelial Malignancies

(2008) M. Krajewska et al.   CLINICAL CANCER RESEARCH

Differential Regulation of Bax and Bak by Anti-apoptotic Bcl-2 Family Proteins Bcl-B and Mcl-1

(2008) Dayong Zhai et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Altered gene expression in busulfan-resistant human myeloid leukemia

(2008) Benigno C. Valdez et al.   LEUKEMIA RESEARCH

Gambogic acid is an antagonist of antiapoptotic Bcl-2 family proteins

(2008) Dayong Zhai et al.   MOLECULAR CANCER THERAPEUTICS